India’s Researchers have conducted a study that shows that the sero-prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – was lower among people living with HIV and AIDS than among the general population.

The team  from the All India Institute of Medical Sciences (AIIMS) in New Delhi, says that studies conducted by the Ministry of Health and Family Welfare in Delhi during June to July, August, and October reported that the SARS-CoV-2 seroprevalence among the Delhi population was 23.5percent, 28.3percent and 25.9percent, respectively.

Now, Naveet Wig and colleagues have shown that among 164 people living with HIV and AIDS (PLHA) in Delhi National Capital Region, the SARS-CoV-2 seroprevalence was 14percent. They also warn that PLHA should not be considered at a lower risk of infection or severe disease and should continue to adhere to social distancing practices and other measures designed to protect against SARS-CoV-2 infection.

Study on Mask: Transparent mask raises comprehension of speech by 10 pc

Third dose for AstraZeneca vaccine produces an improved immune response: Study

Mixing Covid-19 vaccines gives robust protection: Oxford study Report